Defining antimicrobial resistance in cystic fibrosis

Helle Krogh Johansen; Antimicrobial Resistance in Cystic Fibrosis International Working Group

doi:10.1016/j.jcf.2018.08.014

Defining antimicrobial resistance in cystic fibrosis

Helle Krogh Johansen (Member of author group), Antimicrobial Resistance in Cystic Fibrosis International Working Group

Department of Clinical Microbiology

73 Citations (Scopus)

Abstract

Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

Original language	English
Journal	Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Volume	17
Issue number	6
Pages (from-to)	696-704
Number of pages	9
ISSN	1569-1993
DOIs	https://doi.org/10.1016/j.jcf.2018.08.014
Publication status	Published - Nov 2018

Access to Document

10.1016/j.jcf.2018.08.014

Cite this

Defining antimicrobial resistance in cystic fibrosis. / Johansen, Helle Krogh (Member of author group); Antimicrobial Resistance in Cystic Fibrosis International Working Group.
In: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, Vol. 17, No. 6, 11.2018, p. 696-704.

Research output: Contribution to journal › Review › peer-review

@article{ffda56ad3cc14da4b1783033fb848b62,

title = "Defining antimicrobial resistance in cystic fibrosis",

abstract = "Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.",

author = "Kidd, \{Timothy J\} and Rafael Canton and Miquel Ekkelenkamp and Johansen, \{Helle Krogh\} and Peter Gilligan and LiPuma, \{John J\} and Bell, \{Scott C\} and Elborn, \{J Stuart\} and Flume, \{Patrick A\} and VanDevanter, \{Donald R\} and Waters, \{Valerie J\} and \{Antimicrobial Resistance in Cystic Fibrosis International Working Group\}",

year = "2018",

month = nov,

doi = "10.1016/j.jcf.2018.08.014",

language = "English",

volume = "17",

pages = "696--704",

journal = "Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society",

issn = "1569-1993",

publisher = "Elsevier BV",

number = "6",

}

TY - JOUR

T1 - Defining antimicrobial resistance in cystic fibrosis

AU - Kidd, Timothy J

AU - Canton, Rafael

AU - Ekkelenkamp, Miquel

AU - Gilligan, Peter

AU - LiPuma, John J

AU - Bell, Scott C

AU - Elborn, J Stuart

AU - Flume, Patrick A

AU - VanDevanter, Donald R

AU - Waters, Valerie J

AU - Antimicrobial Resistance in Cystic Fibrosis International Working Group

A2 - Johansen, Helle Krogh

PY - 2018/11

Y1 - 2018/11

N2 - Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

AB - Antimicrobial resistance (AMR) can present significant challenges in the treatment of cystic fibrosis (CF) lung infections. In CF and other chronic diseases, AMR has a different profile and clinical consequences compared to acute infections and this requires different diagnostic and treatment approaches. This review defines AMR, explains how it occurs, describes the methods used to measure AMR as well as their limitations, and concludes with future directions for research and development in the area of AMR in CF.

UR - https://www.scopus.com/pages/publications/85053910161

U2 - 10.1016/j.jcf.2018.08.014

DO - 10.1016/j.jcf.2018.08.014

M3 - Review

C2 - 30266518

SN - 1569-1993

VL - 17

SP - 696

EP - 704

JO - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

JF - Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

IS - 6

ER -

Defining antimicrobial resistance in cystic fibrosis

Abstract

Access to Document

Other files and links

Fingerprint

Cite this